KRIT1

Chr 7AD

KRIT1 ankyrin repeat containing

Also known as: CAM, CCM1

This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.503 OMIM phenotypes
Clinical SummaryKRIT1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.32) despite low pLI — interpret in context.
📋
ClinVar Variants
374 unique Pathogenic / Likely Pathogenic· 271 VUS of 845 total submissions
📖
GeneReview available — KRIT1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.50LOEUF
pLI 0.001
Z-score 4.18
OE 0.32 (0.210.50)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.43Z-score
OE missense 0.80 (0.730.88)
315 obs / 394.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.32 (0.210.50)
00.351.4
Missense OE?0.80 (0.730.88)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 14 / 43.8Missense obs/exp: 315 / 394.9Syn Z: -0.24
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveKRIT1-related cerebral cavernous malformationLOFAD

This gene — mechanism propensity

DN
0.5477th %ile
GOF
0.5661th %ile
LOF
0.3744th %ile

The Badonyi & Marsh model scores gain-of-function highest, but genomic evidence most strongly supports loss-of-function (haploinsufficiency) as the primary mechanism.

LOF1 literature citation · 90% of P/LP variants are LoF · LOEUF 0.50

Literature Evidence

LOFOnly the adult patient showed asymptomatic cavernous cerebral malformations on cranial MRI, underlining age-dependent penetrance and haploinsufficiency as pivotal features of patients with KRIT1 mutations.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 17898012

ClinVar Variant Classifications

845 submitted variants in ClinVar

Classification Summary

Pathogenic278
Likely Pathogenic96
VUS271
Likely Benign129
Benign24
Conflicting28
278
Pathogenic
96
Likely Pathogenic
271
VUS
129
Likely Benign
24
Benign
28
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
256
3
19
0
278
Likely Pathogenic
79
7
10
0
96
VUS
3
202
62
4
271
Likely Benign
0
9
45
75
129
Benign
0
0
23
1
24
Conflicting
28
Total33822115980826

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap KRIT1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

KRIT1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →